HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Drug-induced gingival hyperplasia in transplant recipients.

Abstract
Gingival hyperplasia is a common occurrence in transplant recipients who are taking cyclosporine. This condition can be complicated when calcium channel blockers or phenytoin are added to the armamentarium of medications; it can be painful and may interfere with eating, speech, and appearance. Multiple mechanisms exist for gingival overgrowth. Prevention with appropriate oral hygiene appears important in controlling the inflammatory component and decreasing the severity of the overgrowth. Patients must be aware of the potential for the development of gingival hyperplasia and must follow up with regular professional cleanings. If the overgrowth persists, treatment options should be discussed between patients and their physician. Conversion from cyclosporine to tacrolimus, treatment with antibiotic therapy, and surgical excision or laser therapy are all potential therapies to consider.
AuthorsKerri A Hood
JournalProgress in transplantation (Aliso Viejo, Calif.) (Prog Transplant) Vol. 12 Issue 1 Pg. 17-21; quiz 22-3 (Mar 2002) ISSN: 1526-9248 [Print] United States
PMID11993065 (Publication Type: Journal Article, Review)
Chemical References
  • Immunosuppressive Agents
  • Cyclosporine
Topics
  • Cyclosporine (adverse effects)
  • Gingival Hyperplasia (chemically induced)
  • Humans
  • Immunosuppressive Agents (adverse effects)
  • Transplantation (adverse effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: